• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vaccine or monoclonal therapy: which is the winning weapon against COVID-19?

作者信息

Lo Muzio Lorenzo, Bizzoca Maria Eleonora

机构信息

Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy; Istituto Superiore di Sanità, Rome, Italy; CI.N.B.O. (Consorzio Interuniversitario per la Bio-Oncologia), Chieti, Italy.

Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

出版信息

J Glob Antimicrob Resist. 2021 Sep;26:202-204. doi: 10.1016/j.jgar.2021.05.021. Epub 2021 Jul 7.

DOI:10.1016/j.jgar.2021.05.021
PMID:34242802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8260546/
Abstract
摘要

相似文献

1
Vaccine or monoclonal therapy: which is the winning weapon against COVID-19?疫苗还是单克隆疗法：哪一种是对抗新冠病毒的制胜武器？
J Glob Antimicrob Resist. 2021 Sep;26:202-204. doi: 10.1016/j.jgar.2021.05.021. Epub 2021 Jul 7.
2
Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022?鼻用疫苗还是单克隆疗法：哪一个是2022年对抗新冠病毒变异株的制胜武器？
J Glob Health. 2022 May 14;12:03023. doi: 10.7189/jogh.12.03023.
3
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
4
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告：评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
5
Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19.作为针对冠状病毒传染病（COVID-19）的异源人类疫苗，开发 SARS-CoV 受体结合域（RBD）重组蛋白的潜力。
Hum Vaccin Immunother. 2020 Jun 2;16(6):1239-1242. doi: 10.1080/21645515.2020.1740560. Epub 2020 Apr 16.
6
Monoclonal antibody therapy in COVID-19.COVID-19 中的单克隆抗体疗法。
J Biol Regul Homeost Agents. 2021 Mar-Apr;35(2):423-427. doi: 10.23812/Conti_Edit_35_2_1.
7
Super-rapid race for saving lives by developing COVID-19 vaccines.超级快速研发 COVID-19 疫苗以拯救生命。
J Integr Bioinform. 2021 Mar 25;18(1):27-43. doi: 10.1515/jib-2021-0002.
8
SARS-CoV-2: Unique Challenges of the Virus and Vaccines.SARS-CoV-2：病毒和疫苗的独特挑战。
Immunol Invest. 2021 Oct;50(7):802-809. doi: 10.1080/08820139.2021.1936009. Epub 2021 Jun 10.
9
Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.治疗方法和疫苗方面的最新进展，以应对 COVID-19/SARS-CoV-2。
Hum Vaccin Immunother. 2020 Dec 1;16(12):3034-3042. doi: 10.1080/21645515.2020.1794685. Epub 2020 Aug 26.
10
Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development.冠状病毒病（COVID-19）：药物和疫苗研发的现状和前景。
Arch Med Res. 2021 Jan;52(1):15-24. doi: 10.1016/j.arcmed.2020.09.010. Epub 2020 Sep 10.

引用本文的文献

1
Ventricular tachycardia triggered by the first dose of an adenoviral vector-based COVID-19 vaccine in an adult patient with congenital heart disease.一名患有先天性心脏病的成年患者在接种第一剂基于腺病毒载体的新冠疫苗后引发室性心动过速。
Clin Case Rep. 2022 Sep 12;10(9):e6064. doi: 10.1002/ccr3.6064. eCollection 2022 Sep.
2
Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022?鼻用疫苗还是单克隆疗法：哪一个是2022年对抗新冠病毒变异株的制胜武器？
J Glob Health. 2022 May 14;12:03023. doi: 10.7189/jogh.12.03023.